anibamin
novel
pyridin
quaternari
alkaloid
recent
isol
aniba
sp
found
effect
bind
chemokin
receptor
ic
competit
hiv
viral
envelop
protein
bind
high
affin
sinc
gproteincoupl
receptor
essenti
coreceptor
human
immunodefici
viru
type
entri
host
cell
antagonist
inhibit
cellular
entri
provid
new
therapi
choic
treatment
hiv
anibamin
provid
novel
structur
skeleton
remark
differ
lead
compound
previous
identifi
antagonist
report
compar
dock
studi
anibamin
sever
known
antagonist
two
homolog
model
built
base
crystal
structur
bovin
rhodopsin
human
adrenerg
receptor
bind
pocket
anibamin
common
featur
share
high
affin
antagonist
suggest
may
bind
similar
bind
site
andor
mode
time
sever
uniqu
bind
featur
anibamin
identifi
like
prove
benefici
futur
molecular
design
novel
antagonist
base
anibamin
scaffold
accord
unaid
report
estim
million
peopl
worldwid
live
hiv
end
unit
state
one
million
peopl
current
live
hiv
sinc
aid
pandem
remain
one
lead
global
public
health
threat
continu
discoveri
develop
new
antiretrovir
drug
reduc
toxic
enhanc
potenc
novel
mechan
action
reduc
preval
advers
drugdrug
interact
remain
high
prioriti
chemokin
receptor
essenti
coreceptor
requir
attach
host
cell
membran
suggest
antagonist
may
lead
novel
therapeut
strategi
block
entri
hiv
host
cell
especi
util
combin
classic
revers
transcriptas
proteas
inhibitor
time
homoand
heterozyg
genotyp
carrier
shown
confer
either
resist
infect
delay
progress
diseas
therefor
clear
play
essenti
role
hiv
pathogenesi
email
vcuedu
support
inform
avail
goldscor
summari
top
ten
score
last
trial
automat
dock
four
ligand
ramachandran
plot
bovin
rhodopsin
ar
crystal
structur
materi
avail
free
charg
via
internet
http
pubsacsorg
pdb
file
homolog
model
avail
upon
request
chemokin
receptor
figur
belong
extens
exploit
famili
gproteincoupl
receptor
gpcr
chemokin
chemokin
receptor
play
crucial
role
traffick
leukocyt
popul
bodi
involv
develop
wide
varieti
human
diseas
despit
fact
ten
year
sinc
chemokin
receptor
identifi
one
essenti
coreceptor
util
entri
human
cell
current
antagonist
figur
investig
agent
human
clinic
trial
fact
one
drug
maraviroc
selzentri
approv
fda
august
even
though
fda
rais
concern
maraviroc
could
associ
increas
risk
liver
damag
lymphoma
infect
increas
risk
heart
attack
also
clinic
trial
aplaviroc
halt
due
sever
liver
side
effect
treatmentna
treatmentexperienc
patient
note
lead
compound
antagonist
discov
highthroughput
screen
campaign
target
disrupt
viru
attach
coreceptor
often
valid
approach
yield
interest
lead
compound
natur
product
often
divers
novel
structur
skeleton
wider
rang
chemic
shape
structur
featur
well
known
natur
product
offer
unmatch
structur
varieti
compar
combinatori
chemistri
librari
high
divers
specif
biolog
activ
often
make
use
resourc
drug
discoveri
recent
anibamin
novel
pyridin
quaternari
alkaloid
isol
aniba
sp
found
effect
bind
ic
competit
bind
assay
viral
envelop
protein
bind
high
affin
first
natur
product
date
show
antagon
anibamin
novel
structur
quit
differ
known
class
antagonist
recent
report
total
synthesi
anibamin
appli
flexibl
synthet
scheme
allow
product
wide
varieti
analog
note
activ
anibamin
line
lead
compound
develop
antagonist
illustr
figur
anibamin
also
structur
similar
compound
particular
potenti
charg
nitrogen
central
moieti
two
hydrophob
side
chain
attach
howev
structur
novelti
dismiss
possibl
anibamin
may
possess
differ
bind
modal
propos
antagonist
absenc
experiment
structur
data
receptor
one
way
investig
bind
mode
compound
molecular
model
understand
anibamin
bind
mode
may
assist
design
novel
deriv
antagonist
higher
affin
sinc
anibamin
uniqu
chemic
structur
skeleton
potenti
novel
molecular
design
templat
compar
bind
modal
known
antagonist
instruct
regard
activ
valid
lead
compound
next
gener
molecular
design
gener
comput
mathemat
approach
structur
bioinformat
molecular
dock
molecular
pack
pharmacophor
model
mote
carlo
simul
anneal
approach
graphdiagram
approach
diffusioncontrol
reaction
simul
biomacromolecular
intern
collect
motion
simul
qsar
protein
subcellular
locat
predict
identif
membran
protein
type
identif
enzym
function
class
identif
gpcr
type
identif
proteas
type
protein
cleavag
site
predict
signal
peptid
predict
provid
use
inform
insight
basic
research
drug
design
henc
wide
welcom
scienc
commun
specif
absenc
specif
structur
data
molecular
model
studi
build
refin
homolog
model
receptor
dock
variou
ligand
model
access
approach
studi
bind
mode
ligand
like
nearli
gpcr
crystal
structur
receptor
current
avail
templatederiv
homolog
model
use
gain
insight
receptor
structur
fact
homolog
model
method
base
crystal
structur
bovin
rhodopsin
success
appli
gpcr
includ
receptor
understand
ligandprotein
interact
identifi
new
potent
ligand
exampl
homolog
model
angiotensin
ii
type
receptor
use
explor
bind
site
sever
nonpeptid
receptor
antagonist
homolog
model
muscarin
acetylcholin
receptor
appli
understand
mechan
agonistreceptor
complex
activ
g
protein
relev
model
develop
sever
group
help
character
bind
mode
known
agonist
antagonist
believ
lesson
learn
previou
experi
homolog
model
gpcr
base
bovin
rhodopsin
crystal
structur
help
structurebas
drug
design
virtual
screen
therapeut
applic
mani
gpcr
target
recent
semin
resolut
two
human
adrenerg
receptor
ar
crystal
structur
led
us
question
crystal
structur
would
reason
templat
build
homolog
model
receptor
ar
structur
bound
invers
agonist
carazolol
presum
structur
closer
inact
state
ar
howev
broken
ionic
lock
report
structur
increas
affin
chimera
agonist
compar
wild
type
ar
suggest
ar
crystal
structur
seem
closer
activ
state
ar
receptor
possibl
state
activ
inact
thu
homolog
model
base
ar
structur
would
also
worth
explor
valuabl
inform
receptor
studi
bind
mode
anibamin
antagonist
locu
studi
build
analyz
two
complet
ie
includ
extracellular
intracellular
loop
homolog
model
receptor
nearli
homolog
model
gpcr
one
model
base
crystal
structur
bovin
rhodopsin
dark
state
pdb
code
recent
avail
crystal
structur
gpcr
homolog
model
construct
base
crystal
structur
ar
pdb
code
dock
studi
known
antagonist
two
homolog
model
show
homolog
model
base
bovin
rhodopsin
crystal
structur
seem
compat
sitedirect
mutagenesi
studi
result
dock
studi
anibamin
two
homolog
model
show
anibamin
bind
mode
share
common
bind
featur
antagonist
interestingli
uniqu
intermolecular
interact
anibamin
receptor
homolog
model
may
direct
structur
modif
anibamin
lead
next
gener
antagonist
design
comput
analysi
anibamin
process
sever
step
first
perform
conform
studi
known
antagonist
next
homolog
model
chemokin
receptor
includ
transmembran
extracellular
intracellular
compon
built
base
crystal
structur
bovin
rhodopsin
human
ar
follow
molecular
dynam
simulationann
optim
conform
model
final
anibamin
ligand
dock
two
model
particular
emphasi
evalu
bind
pocket
interact
anibamin
known
antagonist
order
simul
conform
anibamin
biolog
system
well
bind
site
conform
studi
conduct
minim
molecular
dynam
simul
compound
report
potenti
antagonist
includ
aplaviroc
maraviroc
vicriviroc
enter
clinic
trial
similarli
analyz
lowest
energi
conform
obtain
ligand
simul
solvat
system
result
appli
initi
conform
explor
bind
mode
receptor
antagonist
bind
locu
conform
expect
provid
reason
start
point
dock
studi
endur
possibl
dramat
alter
dock
order
achiev
lowest
energi
conform
ligandreceptor
complex
vide
infra
chemokin
receptor
belong
rhodopsin
subfamili
gpcr
superfamili
character
heptapeptid
transmembran
helic
fold
span
plasma
membran
see
figur
homolog
model
studi
receptor
base
crystal
structur
dark
state
bovin
rhodopsin
resolut
pdb
code
human
ar
structur
resolut
pdb
code
involv
sever
step
sequenc
align
assign
cartesian
coordin
amino
acid
residu
structur
conserv
region
assign
coordin
amino
acid
residu
structur
nonconserv
region
refin
coordin
side
chain
entir
protein
initi
like
essenti
step
homolog
model
sequenc
align
among
bovin
rhodopsin
human
ar
perform
entir
protein
sequenc
use
insightiihomolog
modul
figur
order
confirm
align
automat
gener
softwar
manual
align
amino
acid
residu
also
perform
compar
chemic
structur
autoalign
residu
entir
protein
sequenc
homolog
level
approxim
among
three
protein
transmembran
domain
gave
homolog
ident
bovin
rhodopsin
human
ar
tabl
valid
appli
two
crystal
structur
templat
construct
homolog
model
receptor
import
note
receptor
sequenc
contain
conserv
amino
acid
residu
found
gpcr
provid
import
guidelin
sequenc
align
overlap
amino
acid
sequenc
rhodopsin
ar
receptor
ie
structur
conserv
region
divid
differ
length
separ
gap
loop
domain
coordin
amino
acid
residu
region
rhodopsin
ar
assign
correspond
residu
receptor
remain
amino
acid
residu
receptor
constitut
structur
nonconserv
region
extracellular
intracellular
loop
region
coordin
residu
region
obtain
search
sequenc
pdb
adopt
conform
nonconserv
region
close
similar
backbon
orient
correspond
region
rhodopsin
ar
side
chain
conform
energi
entir
protein
minim
backbon
constrain
follow
vigor
dynam
simul
reach
energet
reason
conform
local
geometri
energyminim
structur
check
use
insightiihomolog
program
amino
acid
residu
reason
bond
length
bond
angl
analysi
angl
result
protein
conform
conduct
procheck
result
shown
figur
tabl
model
gener
base
ar
templat
better
paramet
use
bovin
rhodopsin
templat
mainli
paramet
differ
two
templat
rather
model
oper
see
support
inform
signific
differ
crystal
structur
bovin
rhodopsin
ar
short
structur
ar
loop
compar
structur
bovin
rhodopsin
gpcr
loop
part
import
ligand
recognit
receptor
thu
concern
structur
receptor
reason
conform
possibl
form
loop
receptor
check
nnpredict
avail
onlin
cohen
group
depart
cellular
molecular
pharmacolog
univers
california
san
francisco
predict
secondari
structur
loop
compar
nnpredict
result
ar
loop
loop
suggest
much
lower
probabl
form
structur
figur
therefor
domain
homolog
model
construct
ar
templat
may
need
scrutin
eg
sitedirect
mutagenesi
data
differ
two
model
assess
figur
overal
weight
root
mean
squar
distanc
rmsd
valu
contrast
rhodopsinderiv
model
domain
arderiv
model
straight
extens
domain
two
model
basic
adopt
fairli
similar
orient
expect
discuss
domain
significantli
differ
ie
rhodopsinderiv
model
present
arderiv
model
present
conform
addit
differ
larg
result
parent
templat
differ
orient
amino
acid
residu
two
model
transmembran
region
also
observ
differ
may
result
specif
bind
pocket
differ
spatial
distribut
hydrophil
hydrophob
region
discuss
dock
studi
result
lowest
energi
conform
anibamin
antagonist
aplaviroc
vicriviroc
maraviroc
conform
studi
first
dock
interact
antagonist
bind
locu
upper
part
transmembran
region
receptor
follow
minim
dynam
simul
result
complex
oper
necess
preliminari
autom
dock
studi
reveal
reason
bind
loci
either
model
due
stringent
steric
arrang
amino
acid
residu
potenti
bind
pocket
conduct
interact
dock
ligand
bind
locu
receptor
thu
identifi
follow
autom
dock
studi
orient
molecul
skeleton
bind
locu
direct
first
put
ionic
interact
tertiari
nitrogen
group
ligand
carboxyl
group
tm
helix
receptor
second
face
hydrophob
side
chain
portion
ligand
toward
hydrophob
tm
helic
dock
valid
short
minim
iter
dynam
simul
step
fs
total
follow
rigor
optim
minim
iter
dynam
simul
step
ps
total
process
backbon
receptor
fix
prevent
disrupt
receptor
bundl
lowest
energi
conform
latter
simul
extract
save
analysi
autom
dock
studi
conduct
use
gold
genet
optim
ligand
dock
default
paramet
gold
permit
full
ligand
flexibl
partial
protein
flexibl
side
chain
backbon
flexibl
ten
userdefin
residu
protein
model
use
dock
ligand
lowest
energi
conform
result
interact
dock
studi
oxygen
atom
defin
activ
site
radiu
receptor
number
trial
conduct
goldscor
dock
trial
record
top
ten
solut
final
trial
save
ligandreceptor
complex
dock
result
highest
goldscor
extract
tabl
seem
differ
bind
anibamin
model
viewpoint
goldscor
three
ligand
tend
bind
better
rel
higher
goldscor
homolog
model
base
bovin
rhodopsin
one
base
ar
final
conform
gold
dock
receptorligand
complex
illustr
figur
major
amino
acid
residu
bind
site
eight
complex
summar
tabl
analys
bind
pocket
anibamin
antagonist
reveal
antagonist
bound
similar
hydrophob
pocket
model
may
occupi
differ
subloci
lead
differ
goldscor
four
ligand
studi
bind
pocket
model
built
mainli
note
residu
share
four
antagonist
model
concord
exist
import
potenti
posit
charg
core
ligand
amphiphil
molecul
anibamin
carri
posit
charg
two
highli
hydrophob
side
chain
thu
surpris
bind
pocket
compos
mainli
aliphat
hydrophob
amino
acid
residu
model
posit
charg
nitrogen
atom
vicin
form
put
salt
bridg
goldscor
model
significantli
differ
tabl
note
observ
signific
interact
anibamin
extracellular
loop
ii
protein
although
vicin
bind
locu
anibamin
homolog
model
sinc
loop
believ
involv
bind
receptor
observ
may
explain
anibamin
inhibit
affin
particularli
outstand
rhodopsinderiv
model
figur
c
e
g
seem
play
import
role
bind
four
ligand
anibamin
probabl
contribut
hydrophob
interact
ligand
receptor
residu
seem
import
bind
anibamin
aplaviroc
amino
acid
residu
uniqu
anibamin
eg
interact
one
long
aliphat
chain
ligand
molecul
also
might
confer
cationpi
andor
pipi
stack
interact
posit
charg
core
ring
system
observ
vicin
arderiv
model
figur
two
long
aliphat
side
chain
anibamin
adopt
complet
differ
orient
rhodopsinderiv
model
lead
differ
set
amino
acid
residu
bind
pocket
thu
instead
part
hydrophob
pocket
also
appear
play
role
recognit
anibamin
antagonist
bind
loci
observ
bind
pocket
appar
signific
differ
orient
two
aliphat
side
chain
molecul
provid
use
inform
futur
valid
bind
mode
well
anibamin
deriv
design
agreement
comprehens
sitedirect
mutagenesi
studi
aplaviroc
show
strong
interact
rhodopsinderiv
model
figur
exampl
may
form
hydrogen
bond
interact
molecul
agreement
report
residu
observ
bind
pocket
aplaviroc
seem
contribut
uniqu
bind
molecul
besid
ionic
hydrogen
bond
interact
carboxyl
acid
moieti
molecul
also
observ
model
hand
observ
similar
interact
acid
moieti
propos
literatur
seem
less
import
report
arderiv
model
figur
bind
pocket
aplaviroc
form
total
differ
set
amino
acid
residu
includ
except
among
residu
test
sitedirect
mutagenesi
studi
deem
essenti
ligand
bind
anoth
report
besid
observ
bind
locu
sinc
involv
bind
pocket
format
model
may
explain
lower
goldscor
aplaviroc
arderiv
model
plausibl
hydrogen
bond
aplaviroc
molecul
may
contribut
significantli
rhodopsinderiv
model
maraviroc
show
weak
interact
region
rhodopsinderiv
model
figur
similar
vicriviroc
import
bind
pocket
maraviroc
model
also
support
sitedirect
mutagenesi
studi
also
part
bind
locu
model
support
sitedirect
mutagenesi
moreov
vicin
ligand
molecul
model
support
literatur
arderiv
model
figur
bind
pocket
maraviroc
show
similar
model
base
rhodopsin
eg
presenc
bind
locu
addit
involv
test
involv
bind
locu
support
sitedirect
mutagenesi
goldscor
two
model
show
signific
differ
top
score
rhodospin
base
model
slightli
higher
ar
base
model
might
come
weak
interact
region
rhodospin
base
model
observ
ar
base
one
anibamin
rhodopsinderiv
model
di
indic
strong
interact
vicriviroc
play
import
role
bind
pocket
figur
agreement
recent
sitedirect
mutagenesi
result
addit
describ
import
residu
bind
pocket
vicriviroc
report
also
signific
interact
ligand
model
hydrophob
interact
ligand
may
signific
base
observ
although
examin
experiment
arderiv
model
figur
bind
pocket
vicriviroc
share
featur
rhodopsinderiv
model
differ
aris
variat
orient
amino
acid
residu
ligand
model
indic
involv
bind
verifi
sitedirect
mutagenesi
howev
observ
bind
pocket
contrari
mutagenesi
data
similarli
role
yet
verifi
major
compon
goldscor
van
del
waal
interact
ligand
receptor
appar
differ
observ
either
model
two
homolog
model
chemokin
receptor
construct
base
crystal
structur
bovin
rhodopsin
human
adrenerg
receptor
respect
anibamin
first
natur
product
antagonist
along
three
wellknown
antagonist
dock
two
model
bind
pocket
ligand
character
compar
report
sitedirect
mutagenesi
studi
model
studi
indic
bind
pocket
four
antagonist
locat
transmembran
tm
part
protein
near
posit
allow
put
ionic
interact
quaternari
nitrogen
common
featur
antagonist
ligand
show
strong
interact
extracellular
loop
rhodopsin
templatebas
model
other
may
directli
influenc
goldscor
bind
fit
rhodopsinderiv
model
arderiv
model
four
ligand
tend
adopt
similar
bind
locu
ligand
bind
mode
orient
somewhat
differ
two
model
certainli
relat
differ
conform
tm
domain
orient
amino
acid
side
chain
crystal
structur
templat
model
base
importantli
futur
work
anibamin
share
mani
common
bind
featur
known
ligand
model
thu
suggest
inhibit
activ
may
stem
bind
antagonist
bind
locu
studi
crystal
structur
bovin
rhodopsin
human
ar
seem
reason
templat
conduct
homolog
model
oper
receptor
rhodopsinderiv
model
receiv
support
report
sitedirect
mutagenesi
studi
known
antagonist
bind
pocket
ligand
identifi
arderiv
model
need
verifi
extens
experiment
studi
anibamin
interest
lead
compound
antihiv
drug
discoveri
first
natur
product
antagonist
identifi
far
uniqu
skeleton
recent
report
flexibl
total
synthesi
anibamin
open
number
research
direct
particular
pursu
next
gener
molecular
design
base
uniqu
bind
featur
anibamin
may
yield
clinic
relev
antagonist
bind
mode
studi
anibamin
homolog
model
report
herein
benefici
futur
studi
novel
drug
design
develop
sequenc
human
chemokin
receptor
obtain
http
wwwexpasyorg
swissprot
trembl
crystal
structur
bovin
rhodopsin
human
ar
download
http
wwwrcsborg
comput
perform
sgi
workstat
silicon
graphic
inc
mountain
view
ca
homolog
model
carri
use
homolog
discov
modul
insightii
packag
accelri
san
diego
ca
sequenc
align
conduct
automat
appli
differ
score
matric
gap
penalti
gap
length
penalti
paramet
order
achiev
highest
sequenc
homolog
coordin
amino
acid
residu
structur
conserv
region
assign
follow
correspond
residu
receptor
coordin
amino
acid
residu
receptor
structur
nonconserv
region
obtain
search
protein
databas
insightiihomologyloopsearch
modul
complet
amino
acid
residu
coordin
assign
conform
whole
protein
minim
backbon
constrain
brief
minim
iter
dynam
simul
step
femtosecond
step
conduct
relax
major
steric
clash
introduc
coordin
assign
vigor
simul
minim
iter
dynam
step
ps
total
conduct
produc
energet
reason
conform
forc
field
appli
minim
termin
maximum
deriv
less
kcalmol
small
ligand
molecul
built
use
insightiibuild
modul
minim
steepest
descent
follow
conjug
gradient
perform
gener
lowest
energi
conform
ligand
studi
forc
field
default
termin
valu
adopt
molecular
dynam
simul
perform
equilibr
phase
fs
k
follow
collect
phase
fs
temperatur
studi
small
molecul
conform
use
lowest
energi
conform
small
molecul
water
extract
ps
molecular
dynam
calcul
initi
configur
dock
propos
bind
site
receptor
ligand
model
nitrogenproton
form
applic
interact
dock
studi
conduct
discov
modul
insightii
ligand
dock
upper
portion
transmembran
region
receptor
follow
orient
report
literatur
ligandreceptor
complex
minim
ga
phase
first
backbon
receptor
fix
side
chain
atom
left
unconstrain
optim
conform
use
initi
configur
molecular
dynam
simul
complex
shortterm
steepest
descent
energi
minim
iter
dynam
simul
step
fs
step
conduct
valid
initi
dock
conform
follow
anoth
simul
minim
iter
step
dynam
conduct
initi
step
equilibr
total
simul
time
ps
forc
field
default
termin
valu
kcalmol
adopt
autom
dock
conduct
gold
default
paramet
adopt
except
dock
locu
defin
around
helix
base
fit
score
bind
orient
ligand
best
solut
gold
bind
among
top
ten
solut
record
select
merg
structur
receptor
combin
structur
ligand
receptor
minim
togeth
order
allow
receptor
adopt
presenc
ligand
ligand
remov
complex
result
structur
evalu
procheck
dock
result
summar
tabl
final
model
optim
molecular
dynam
simul
use
default
paramet
except
follow
length
fs
snapshot
everi
fs
time
step
fs
dielectr
constant
chemic
structur
anibamin
sever
known
potenti
antagonist
sequenc
align
human
bovin
rhodopsin
bovn
pdb
code
human
ar
pdb
code
ballesterosweinstein
number
system
adopt
mark
conserv
amino
acid
residu
among
gpcr
color
red
protein
number
accordingli
sequenc
secondari
structur
receptor
conform
base
bovin
rhodopsin
crystal
structur
mark
sequenc
ramachandran
plot
rhodopsinbas
b
arbas
receptor
homolog
model
ar
secondari
structur
predict
h
helix
e
strand
predict
homolog
model
overlap
ribbon
model
base
bovin
rhodopsin
crystal
structur
red
one
base
ar
green
bind
mode
antagonist
homolog
model
construct
base
bovin
rhodopsin
red
human
ar
green
amino
acid
residu
bind
pocket
shown
cap
stick
ligand
ball
stick
receptor
model
ribbon
el
part
tm
omit
clariti
oxygen
atom
red
fluorin
green
nitrogen
deep
blue
carbon
atom
bond
color
accord
ligand
b
anibamin
orang
c
aplaviroc
yellow
e
f
maraviroc
purpl
g
h
vicriviroc
cyan
tabl
sequenc
homolog
analysi
receptor
bovin
rhodopsin
adrenerg
receptor
tabl
data
ramachandran
plot
rhodopsinand
adrenerg
receptorbas
homolog
model
total
number
amino
acid
receptor
model
top
goldscor
anibamin
three
known
antagonist
dock
homolog
model
